133 results on '"Hogan, William J."'
Search Results
2. Severe Late Agranulocytosis Post-Allogeneic Stem Cell Transplant during Tacrolimus Taper
3. Factors Predicting Survival in Patients with TP53-Mutated Myeloid Neoplasms Following Allogeneic Stem Cell Transplant
4. Ibrutinib for Therapy of Steroid-Refractory Chronic Graft Vs. Host Disease: A Multicenter Real-World Analysis
5. Coronary Artery Calcium As a Predictor of Non-Relapse Mortality and Overall Survival in Patients Undergoing Post-Transplant Cyclophosphamide As Gvhd Prophylaxis
6. Donor Search and Selection Strategy to Facilitate Comparable Transplant Rates across Donor Search Prognosis Groups: A Report from the BMT CTN 1702 Trial
7. The Mount Sinai Acute Gvhd International Consortium (MAGIC) Model: An Integrated Clinical and Biomarker Grading System for Acute Graft-Versus-Host Disease (GVHD)
8. Chronic Graft-Versus-Host Disease Leptomeningitis Following Allogeneic Stem Cell Transplant.
9. Impact of Wilms Tumor (WT1) Mutation on Relapse and Overall Survival in Acute Myeloid Leukemia Patients Following Allogenic Stem Cell Transplantation
10. Outcomes of HLA-DPB1 Mismatch in Patients Receiving Post-Transplant Cyclophosphamide for Graft Versus Host Disease Prophylaxis
11. Pilot Prospective Study of Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Vexas Syndrome
12. The MAGIC Algorithm Probability Predicts Treatment Response and Long-Term Outcomes to Second-Line Therapy for Acute Gvhd
13. A Day 14 Endpoint for Acute GVHD Clinical Trials
14. Long-Term Pulmonary Function Trajectories After Allogeneic Bone Marrow Transplantation
15. Comparison of Pretransplantation Prediction Models for Nonrelapse Mortality in Patients with Myelofibrosis Undergoing Allogeneic Stem Cell Transplantation
16. Pericardial Effusion as a Purported Manifestation of Graft-versus-Host Disease following Allogeneic Hematopoietic Cell Transplantation
17. Risk Factors and Outcomes of Nocardiosis in Hematopoietic Stem Cell Transplantation Recipients
18. Allogeneic Hematopoietic Stem Cell Transplantation in the Outpatient Setting: The Mayo Clinic Experience
19. Prediction of Atrial Arrhythmia after Allogenic Transplantation Using Artificial Intelligence-Enabled ECG
20. Cpss Cytogenetics and Easix Score Based Composite Survival Model for Patients with CMML Undergoing Allogeneic Transplant
21. Efficacy of Donor Lymphocyte Infusions in Achieving Disease Control Among Myeloid Malignancy Patients Treated with an Allogeneic Hematopoietic Stem Cell Transplantation
22. Hematopoietic Stem Cell Transplant Outcome in STAG2-Mutated Myeloid Neoplasms
23. De Novo Late Acute Gvhd: Incidence, Outcomes, and Impact of Biomarkers Compared to Classic Acute Gvhd
24. Surrogates of Endothelial Injury Predict Non-Relapse Mortality Among Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide-Based Gvhd Prophylaxis
25. Allogeneic Stem Cell Transplant Outcomes in Patients with DDX41 Mutated Myeloid Malignancies
26. Factors Predicting Survival Following Allogeneic Stem Cell Transplant in Patients with Therapy-Related Myeloid Neoplasms
27. Clinical Outcomes of Pretransplant Mortality Prediction Models in Patients with Myelofibrosis Undergoing Allogeneic Hematopoietic Stem Cell Transplant
28. Elevated Pre-Transplant Ferritin Is Associated with Development of Liver Graft-Vs-Host Disease in Myelodysplastic Syndromes Following Allogeneic Stem Cell Transplantation
29. Second Stem Cell Transplantation for Relapsed Refractory Light Chain (AL) Amyloidosis
30. Epidemiology, Risk Factors, and Outcomes of Diffuse Alveolar Hemorrhage After Hematopoietic Stem Cell Transplantation
31. Outcomes Following Allogeneic Stem Cell Transplant for Therapy-Related Myeloid Neoplasm
32. Pneumatosis Is a Rare but Serious Manifestation of Gastrointestinal Graft-Vs.-Host Disease Following Allogeneic Stem Cell Transplant
33. Intestinal Pneumatosis and Perforation Are a Rare but Serious Manifestation of Gastrointestinal Graft-Vs.-Host Disease Following Allogeneic Stem Cell Transplant
34. Clinical Outcomes of Post Allogeneic Stem Cell Transplant Splenectomy in Primary Myelofibrosis for Delayed Engraftment
35. Impact of Novel Targeted Therapies and Cytogenetic Risk Groups on Outcome After Allogeneic Transplantation for Adult ALL
36. Chronic graft-versus-host disease in pancreas after kidney transplant recipients – An unrecognized entity
37. Leukocytosis and Tobacco Use: An Observational Study of Asymptomatic Leukocytosis
38. Prognostic Role of Beta-2 Microglobulin in Patients with Light Chain Amyloidosis Treated with Autologous Stem Cell Transplantation
39. Low-Dose Total Body Irradiation (TBI) Use As Part of Pre-Transplant Conditioning Regimen Is Associated with Worse Outcomes in Patients with Severe Aplastic Anemia (SAA) Treated with Allogeneic Hematopoietic Stem Cell Transplantation (HCT)
40. The MAGIC Algorithm Probability (MAP) Is a Validated Response Biomarker of Treatment for Acute Graft-Versus-Host Disease
41. The Impact of Proliferating Polyclonal Plasma Cells on Outcome after Autologous Stem Cell Transplantation in Multiple Myeloma
42. Use of Sublingual Tacrolimus in Adults Undergoing Hematopoietic Cell Transplant: A Pilot Study
43. Utilization of Cryopreserved Stem Cell Re-Infusion without Conditioning Chemotherapy in Primary and Secondary Autologous Graft Failure Following an Autologous Stem Cell Transplant in Multiple Myeloma
44. Clinical Applications and Utility of a Precision Medicine Approach for Patients With Unexplained Cytopenias
45. Outcome of Myelodysplastic Syndromes Over Time in the United States: A National Cancer Data Base Study From 2004-2013
46. Outcomes of Patients with Light Chain Amyloidosis Who Had Autologous Stem Cell Transplantation with 3 or More Organs Involved
47. Utilization and Outcomes of Fertility Preservation Techniques in Women Undergoing Allogeneic Hematopoietic Cell Transplant
48. Long-Term Outcomes after Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome
49. Comparison of Gvhd Biomarker Algorithms for Predicting Lethal Gvhd and Non-Relapse Mortality
50. Autologous Stem Cell Transplant for IgM Related AL Amyloidosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.